Raymond James Financial Aktie
153,84USD | -1,08USD | -0,70% |
WKN: 875072 / ISIN: US7547301090
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 89,95 |
The Vanguard Group, Inc. | 10,93 |
Vanguard Group, Inc. (Subfiler) | 10,34 |
Thomas Alan James | 9,47 |
PRIMECAP Management Co. | 6,04 |
PRIMECAP Management Co. | 5,87 |
Wellington Management Co. LLP | 5,53 |
Wellington Management Co. LLP (Wellington Breakout) | 5,31 |
State Street Corp. | 3,91 |
Vanguard Total Stock Market ETF | 2,86 |
BlackRock Fund Advisors | 2,69 |
Fidelity Management & Research Co. LLC | 2,41 |
Vanguard 500 Index Fund | 2,41 |
Geode Capital Management LLC | 2,13 |
Vanguard PRIMECAP Fund | 2,11 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 19 635 | 20 021 | 22 043 | 23 019 | 23 961 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,42 | 0,49 | 0,51 | 0,57 | 0,62 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 0 | 0 | 0 | 0 | 0 |
Summe Anlagevermögen | 0 | 0 | 0 | 0 | 0 |
Summe Aktiva | 47 707 | 62 156 | 80 951 | 78 360 | 82 992 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 40 531 | 53 853 | 71 519 | 68 173 | 71 325 |
Summe Eigenkapital | 7 176 | 8 303 | 9 432 | 10 187 | 11 667 |
Summe Passiva | 47 707 | 62 156 | 80 951 | 78 360 | 82 992 |
Adresse
880 Carillon Parkway, 33716 St. Petersburg | |
Telefon | +1 (727) 567-1000 |
Internet | http://www.raymondjames.com |
Management
Andy Zolper
Chief Information Technology Security Officer |
Anne Gates
Independent Non-Executive Director |
Art A. Garcia
Independent Non-Executive Director |
Bella Loykhter Allaire
Chief Administrative Officer |
Benjamin C. Esty
Independent Non-Executive Director |
Bradley Ward Sussman
VP-Alternative Investments Product Development |
Calvin Sullivan
Chief Strategy Officer-Fixed Income Division |
Cecily Mistarz
Independent Director |
Chad Runnels
Senior Vice President |
Christopher S. Aisenbrey
Chief Human Resources Officer |
Chuck Ellingsworth
Managing Director |
David De Luca
Senior Managing Director & Head-Global Equities |
David Krauss
Chief Risk Officer |
Doug Brigman
Chief Administrative Officer-Asset Management |
Gavin Murrey
Executive Vice President & Head-Public Finance |
Gordon L. Johnson
Independent Non-Executive Director |
Guy Logan
Managing Director-Atlanta Region |
Horace Carter
President-Fixed Income |
Jack A. Dudick
MD-Healthcare Finance Gp, Head-Healthcare Real Est |
James E. Bunn
President-Capital Markets |
Jay Hernandez
Managing Director-Boston |
Jeffrey N. Edwards
Lead Independent Non-Executive Director |
Jonathan N. Santelli
Secretary, Executive VP & General Counsel |
Jonathan Oorlog
Chief Financial Officer |
K. Gregory Rust
Senior Vice President-Operations |
Katherine H. Larson
Chief Accounting Officer |
Kevin J. Kooman
Managing Director-Investment Banking |
Kristina R. Waugh
Vice President-Investor Relations |
Leslie Ann Brooks Curry
Chief Experience Officer-Investment Banking |
Marlene B. Debel
Independent Non-Executive Director |
Mike White
Chief Marketing Officer |
Parker Colvin
Managing Director |
Paul C. Reilly
Chairman & Chief Executive Officer |
Paul M. Shoukry
President & Director |
Raj Seshadri
Independent Non-Executive Director |
Raymond W. McDaniel
Independent Non-Executive Director |
Roderick C. McGeary
Independent Non-Executive Director |
Scott Alan Curtis
Chief Operating Officer |
Steve LaBarbera
Chief Compliance Officer |
Stuart Barich
Managing Dir-Life Sciences Investment Banking Team |
TJ Haynes-Morgan
Chief Audit Executive |
Tarek Helal
Chief Strategy Officer |
Tashtego Spring Elwyn
President-Private Client Group |
Vin Campagnoli
Executive Vice President-Technology & Operations |